New deal supports French pharma and biotech
December 1, 2009Research and Development, Sales and Marketing France, biotech
The French government has agreed a new deal with industry leaders to help the country’s pharma and biotech industries.President Sarkozy …
PPD buys BioDuro to get bigger in China
December 1, 2009Research and Development CRO, China, em
Pharmaceutical Product Development (PPD) has expanded its capacity to offer drug development services in Asia once again with the acquisition …
Building value – is the pipeline all that matters?
December 1, 2009Research and Development Les Rose, biotech, venture capital
Venture capital is a curious business and the global financial crisis in which we find ourselves has exposed some rather …
Incyte’s Novartis cancer drug deal could be worth $1bn
December 1, 2009Research and Development Incyte, Novartis
Novartis has paid Incyte Corporation $150 million up front for the rights to two oral investigational hematology-oncology therapies.The first is …
Shire files for Gaucher drug in Europe
December 1, 2009Sales and Marketing Cerezyme, Gaucher, Shire
Shire has followed up its marketing applications for Gaucher disease treatment velaglucerase alfa in the US and Canada with a …
UK faces north/south divide on cancer
December 1, 2009Sales and Marketing Cancer, NHS
There is a marked north/south divide when it comes to cancer patients’ chances of recovery, according to new statistics. The …
Drugmakers look to property portfolios for cost-savings
December 1, 2009Manufacturing and Production CB Richard Ellis, property
Increasing numbers of pharmaceutical companies are cutting costs by selling properties and leasing them back off the new owners, according …
Manufacturing news in brief
December 1, 2009Manufacturing and Production Aurobindo, Servier
Our periodic round-up of developments in the pharmaceutical manufacturing sector reveals a crop of facility news, with capital investments at …
New market access approach could save poorer countries millions
December 1, 2009Sales and Marketing HIV, access, developing world
An innovative approach to improving access to drugs for HIV/Aids, tuberculosis and malaria could save poorer countries millions of …
Plan to bypass NICE put out for consultation
December 1, 2009Sales and Marketing ABPI, Drayson, NICE
The UK government is seeking industry input on its proposed pilot scheme to improve patient access to innovative drugs …
EU should require all trials to be registered, says IQWiG
December 1, 2009Sales and Marketing Germany, IQWIG, health economics, hta
Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) has said that registration and publication of all clinical trials …
Hervé Duchesne de Lamotte, chief financial officer, ExonHit Therapeutics
December 1, 2009Research and Development ExonHit Therapeutics, appointment, research and development
ExonHit Therapeutics appoints Hervé Duchesne de Lamotte chief financial officer.The Paris-based company develops innovative molecular diagnostic tests and therapeutics for …
Genzyme hit by another contamination issue
November 30, 2009Manufacturing and Production Cerezyme, Contamination, Genzyme
Another manufacturing contamination issue has beset Genzyme, just as it seemed to be overcoming the problems at its Allston Landing …
Manufacturing news in brief
November 30, 2009Manufacturing and Production Abraxis, DSM, Hovione, Lonza
Pharmafocus’ round-up of developments in the pharmaceutical manufacturing sector includes new contracts for CMOs Lonza and DSM, facility news for …
New patient rights on the horizon
November 30, 2009Medical Communications NHS, patient rights
The government’s much-vaunted improvements in hospital waiting times could have a basis in law as early as next April.Under new …
NHS promotes self-care
November 30, 2009Sales and Marketing NHS, chronic, self care
The NHS has run its first national week of events promoting the benefits for people in taking control of their …
GSK licences smoking vaccine candidate
November 30, 2009Research and Development GSK, Nabi, smoking, vaccines
GlaxoSmithKline Biologicals has signed a licensing agreement for a nicotine vaccine candidate currently in the first of two phase III …
Clinical research news in brief
November 30, 2009Research and Development CRO, Clinipace, ICON, Parexel
Pharmafocus’ latest round-up of clinical research news includes a new US registry to aid patient recruitment, alliances for ICON, Parexel …
RPSGB appoints Neal Patel Head of Corporate Communications
November 30, 2009Sales and Marketing NHS, UK, appointment, rpsgb
The Royal Pharmaceutical Society of Great Britain (RPSGB) has appointed Neal Patel as head of corporate communications.Neal will join the …
EMA: Aligning regulation with the lifecycle of medicines
November 30, 2009Research and Development EMA, EMEA, Thomas Lönngren, regulatory affairs
The European Agency for the Evaluation of Medicinal Products was set up in 1995 in London’s Docklands, an isolated eastern …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
